Biological function of nuclear receptor tyrosine kinase action

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 7, 2013, Pages

  Song, Sungmin ^a,b   Rosen, Kenneth M ^a,b   Corfas, Gabriel ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ACTIVE TRANSPORT; ARTICLE; BIOLOGICAL MODEL; CELL NUCLEUS; LIVER; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; LIVER; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84879766303     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a009001     Document Type: Article

References (63)

1. Adilakshmi T, Ness-Myers J, Madrid-Aliste C, Fiser A, Tapinos N. 2011. A nuclear variant of ErbB3 receptor tyrosine kinase regulates ezrin distribution and Schwann cell myelination. J Neurosci 31: 5106-5119.
2. Allison JG, Das PM, Ma J, Inglis FM, Jones FE. 2011. The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons. Neurosci Res 70: 155-163.
3. Arasada RR, Carpenter G. 2005. Secretase-dependent tyrosine phosphorylation ofMdm2 by the ErbB-4 intracellular domain fragment. J Biol Chem 280: 30783-30787.
4. Beguelin W, Diaz Flaque MC, Proietti CJ, Cayrol F, Rivas MA, Tkach M, Rosemblit C, Tocci JM, Charreau EH, Schillaci R, et al. 2010. Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3. Mol Cell Biol 30: 5456-5472.
5. Bonacchi A, Taddei ML, Petrai I, Efsen E, Defranco R, Nosi D, Torcia M, Rosini P, Formigli L, Rombouts K, et al. 2008. Nuclear localization of TRK-A in liver cells. Histol Histopathol 23: 327-340.
6. Cassiman D, Denef C, Desmet VJ, Roskams T. 2001. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 33: 148-158.
7. Chen QQ, Chen XY, Jiang YY, Liu J. 2005. Identification of novel nuclear localization signal within the ErbB-2 protein. Cell Res 15: 504-510.
8. Citri A, Skaria KB, Yarden Y. 2003. The deaf and the dumb: The biology of ErbB-2 and ErbB-3. Exp Cell Res 284: 54-65.
9. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R, Rodemann HP. 2005. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 280: 31182-31189.
10. Dittmann K, Mayer C, Kehlbach R, Rodemann HP. 2008. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. Radiother Oncol 86: 375-382.
11. Domingues I, Rino J, Demmers JA, de Lanerolle P, Santos SC. 2011. VEGFR2 translocates to the nucleus to regulate its own transcription. PLoS ONE 6: e25668.
12. Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD, Klagsbrun M. 1997. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem 272: 26761-26768.
13. Elenius K, Choi CJ, Paul S, Santiestevan E, Nishi E, Klagsbrun M. 1999. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase. Oncogene 18: 2607-2615.
14. Fang X, Stachowiak EK, Dunham-Ems SM, Klejbor I, Stachowiak MK. 2005. Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: A novel mechanism of gene regulation. J Biol Chem 280: 28451-28462.
15. Folkman J. 2007. Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
16. Fortini ME. 2002. g-Secretase-mediated proteolysis in cellsurface-receptor signalling. Nat Rev Mol Cell Biol 3: 673-684.
17. Giri DK, Ali-Seyed M, Li LY, Lee DF, Ling P, Bartholomeusz G, Wang SC, Hung MC. 2005. Endosomal transport of ErbB-2: Mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 25: 11005-11018.
18. Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y, Hung MC. 2006. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol Carcinog 45: 10-17.
19. Harmer NJ. 2006. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans 34: 442-445.
20. Horbinski C, Stachowiak EK, Chandrasekaran V, Miuzukoshi E, Higgins D, Stachowiak MK. 2002. Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. J Neurochem 80: 54-63.
21. Hsu SC, Miller SA, Wang Y, Hung MC. 2009. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am J Transl Res 1: 249-258.
22. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML, Chuang YH, Lai CH, Chang WC. 2008. Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 36: 4337-4351.
23. Hynes NE, MacDonald G. 2009. ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 21: 177-184.
24. Jones FE, Welte T, Fu XY, Stern DF. 1999. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol 147: 77-88.
25. Junttila TT, Sundvall M, Lundin M, Lundin J, Tanner M, Harkonen P, Joensuu H, Isola J, Elenius K. 2005. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res 65: 1384-1393.
26. Koumakpayi IH, Diallo JS, Le Page C, Lessard L, Gleave M, Begin LR, Mes-Masson AM, Saad F. 2006. Expression and nuclear localization of ErbB3 in prostate cancer. Clin Cancer Res 12: 2730-2737.
27. Koumakpayi IH, Le Page C, Delvoye N, Saad F, Mes-Masson AM. 2011. Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells. Mol Carcinog 50: 901-912.
28. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. 1989. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci 86: 9193-9197.
29. Lai C, Feng L. 2004. Implication of g-secretase in neuregulin-induced maturation of oligodendrocytes. Biochem Biophys Res Commun 314: 535-542.
30. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
31. LeRoith D, Roberts CT Jr. 2003. The insulin-like growth factor system and cancer. Cancer Lett 195: 127-137.
32. Li LY, Chen H, Hsieh YH, Wang YN, Chu HJ, Chen YH, Chen HY, Chien PJ, Ma HT, Tsai HC, et al. 2011. Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes. Cancer Res 71: 4269-4279.
33. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808.
34. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y, Bartholomeusz G, Shih JY, Hung MC. 2005. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7: 575-589.
35. Lo HW, Cao X, Zhu H, Ali-Osman F. 2010. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFRSTAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res 8: 232-245.
36. Long W, Wagner KU, Lloyd KC, Binart N, Shillingford JM, Hennighausen L, Jones FE. 2003. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130: 5257-5268.
37. Lyu J, Yamamoto V, Lu W. 2008. Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell 15: 773-780.
38. Myers JM, Martins GG, Ostrowski J, Stachowiak MK. 2003. Nuclear trafficking of FGFR1: A role for the transmembrane domain. J Cell Biochem 88: 1273-1291.
39. Ni CY, Murphy MP, Golde TE, Carpenter G. 2001. g-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294: 2179-2181.
40. Nusse R. 2005. Wnt signaling in disease and in development. Cell Res 15: 28-32.
41. Offterdinger M, Schofer C, Weipoltshammer K, Grunt TW. 2002. c-erbB-3: A nuclear protein in mammary epithelial cells. J Cell Biol 157: 929-939.
42. Peng H, Myers J, Fang X, Stachowiak EK, Maher PA, Martins GG, Popescu G, Berezney R, Stachowiak MK. 2002. Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J Neurochem 81: 506-524.
43. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M. 1993. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci 90: 1746-1750.
44. Reichardt LF. 2006. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361: 1545-1564.
45. Rio C, Buxbaum JD, Peschon JJ, Corfas G. 2000. Tumor necrosis factor-a-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem 275: 10379-10387.
46. Santos SC, Miguel C, Domingues I, Calado A, Zhu Z, Wu Y, Dias S. 2007. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res 313: 1561-1574.
47. Sardi SP, Murtie J, Koirala S, Patten BA, Corfas G. 2006. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127: 185-197.
48. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA. 1984. The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312: 513-516.
49. Schlessinger J, Lemmon MA. 2006. Nuclear signaling by receptor tyrosine kinases: The first robin of spring. Cell 127: 45-48.
50. Sehat B, Tofigh A, Lin Y, Trocme E, Liljedahl U, Lagergren J, Larsson O. 2010. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 3: ra10.
51. Shi F, Telesco SE, Liu Y, Radhakrishnan R, Lemmon MA. 2010. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proc Natl Acad Sci 107: 7692-7697.
52. Stachowiak MK, Maher PA, Joy A, Mordechai E, Stachowiak EK. 1996a. Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol Biol Cell 7: 1299-1317.
53. Stachowiak MK, Maher PA, Joy A, Mordechai E, Stachowiak EK. 1996b. Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res Mol Brain Res 38: 161-165.
54. Stachowiak MK, Fang X, Myers JM, Dunham SM, Berezney R, Maher PA, Stachowiak EK. 2003. Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation. J Cell Biochem 90: 662-691.
55. Sundvall M, Iljin K, Kilpinen S, Sara H, Kallioniemi OP, Elenius K. 2008. Role of ErbB4 in breast cancer. J Mammary Gland Biol Neoplasia 13: 259-268.
56. Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP. 2003. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci 100: 8281-8286.
57. van Amerongen R, Nusse R. 2009. Towards an integrated view of Wnt signaling in development. Development 136: 3205-3214.
58. Vecchi M, Baulida J, Carpenter G. 1996. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem 271: 18989-18995.
59. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, et al. 2004. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6: 251-261.
60. Wang SC, Nakajima Y, Yu YL, Xia W, Chen CT, Yang CC, McIntush EW, Li LY, Hawke DH, Kobayashi R, et al. 2006. Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 8: 1359-1368.
61. Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE. 2004. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 167: 469-478.
62. Zhou W, Carpenter G. 2000. Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem 275: 34737-34743.
63. Zhu Y, Sullivan LL, Nair SS, Williams CC, Pandey AK, Marrero L, Vadlamudi RK, Jones FE. 2006. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res 66: 7991-7998.